Top compounds associated with response to LIX1L


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA B02 CTRPv2 pan-cancer AAC 0.097 0.02
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.03
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.081 0.03
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.03
mRNA etomoxir CTRPv2 pan-cancer AAC -0.098 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.093 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.03
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.3 0.03
Download CSV